Form 8 (DD) - Futura Medical
Futura Medical PLC has amended its Form 8 (DD) disclosure, originally released on 29/09/2026, to fill in previously blank sections 2(b) and 3(d). The Chief Executive Officer, Alexander Duggan, disclosed dealings on 25 September 2026, resulting in interests of 17,500,000 ordinary shares, representing 1.18% of the company. Additionally, Mr. Duggan has rights to subscribe for 29,056,032 ordinary shares under the 26 LTIP plan, with options exercisable at 0.2p. The amended filing also details a subscription for 12,500,000 ordinary shares at 0.2p each as part of a recent Conditional Placing.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Amendments were made to sections 2(b) and 3(d). The tables were previously blank but have now been filled with the correct information.
The full amended text is shown below.
FORM 8 (DD)
Rules 8.1, 8.2 and 8.4 of the Takeover Code (the “Code”)
KEY INFORMATION
| (a) Full name of discloser: | Alexander Duggan | ||
| (d) Status of person making the disclosure: e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree) | Chief Executive Officer | ||
| (e) Date dealing undertaken: | 25 September 2026 | ||
| 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE | |||
| Class of relevant security: | Ordinary Shares of 0.2p each | ||
| Interests | Short positions | ||
| Number | % | Number | % |
| (1) Relevant securities owned and/or controlled: | 17,500,000 | 1.18 | |
- Cash-settled derivatives:
- Stock-settled derivatives (including options) and agreements to purchase/sell:
| TOTAL: | 17,500,000 | 1.18 |
All interests and all short positions should be disclosed.
- Rights to subscribe for new securities (including directors’ and other employee options)
| Class of relevant security in relation to which subscription right exists: | Ordinary Shares of 0.2p each |
| Details, including nature of the rights concerned and relevant percentages: | Share plan No of ordinary shares under options / awards Date of award Exercise price (per share) Vesting date Expiry date 26 LTIP 29,056,032 15 January 26 0.2p 15 January 2027 15 July 2027 |
DEALINGS BY THE PERSON MAKING THE DISCLOSURE
The currency of all prices and other monetary amounts should be stated.
Purchases and sales
| Class of relevant security | Purchase/sale | Number of securities | Price per unit |
- Cash-settled derivative transactions
- Stock-settled derivative transactions (including options)
- Writing, selling, purchasing or varying
- Exercise
- Other dealings (including subscribing for new securities)
| Ordinary shares of 0.2p each* | Subscription of 12,500,000 Ordinary Shares* | Subscribed for as part of the recent Conditional Placing* | 0.2p* |
- OTHER INFORMATION
- Indemnity and other dealing arrangements
- Agreements, arrangements or understandings relating to options or derivatives
- Attachments
Are any Supplemental Forms attached?
| Supplemental Form 8 (Open Positions) | NO |
| Supplemental Form 8 (SBL) | NO |
| Date of disclosure: | 29 September 2026 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.